Search

The Memorial Sloan Kettering – Hackensack Meridian Health Partnership has formed an Immunology Research Collaboration to support innovative investigations into the power of the immune system to fight cancer.

… Tuesday, June 9, 2020 As part of the Memorial Sloan Kettering – Hackensack Meridian Health Partnership, the two organizations have formed an Immunology Research Collaboration. Through this joint initiative, researchers can apply for funding to support innovative investigations to explore the power of

… Full Title exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson’s Disease (Advarra IRB) Purpose Researchers want to see if bemdaneprocel improves symptoms in people with Parkinson’s disease (PD). PD

Meet Mark McIntosh, who is free of cancer and back to work as an actor after being treated for bladder cancer at Memorial Sloan Kettering.

… Hear from Our Patients How I Took the Stage after Bladder Cancer: Mark's Story New York City actor Mark McIntosh was diagnosed with bladder cancer after he saw blood in his urine. MSK urologic surgeon Bernard Bochner ultimately removed Mark’s bladder and gave him a substitute that wouldn’t require an

… Associate Director: Nancy Lee Project Description: In recent years, there has been a rise in cases of head and neck cancer caused by the human papillomavirus (HPV). Increasingly, young men who are nonsmokers and are otherwise in good health have been found to have oropharyngeal cancer. This includes

… Job Title GSK PhD Student Fellowships Jonas E. Salk Scholarship 2022 Kravis WiSE Graduate Fellowship (2022-2025) Education BS, The City College of New York; Cancer Biology Mentor The Andrea Schietinger Lab Start Year 2019 Email [email protected]

An antibody that targets a prostate cell protein shows potential for designing safer, more effective prostate cancer therapies.

… Tuesday, April 24, 2018 Summary Current prostate cancer drugs often lose their effectiveness over time. A new approach involves using an antibody to deliver toxic radioactive particles selectively to prostate cancer cells. There are many effective prostate cancer drugs, but a major challenge is that

Shi Chen studies organic chemistry and chemical biology in the Tan laboratory at MSKCC.

… Job Title TPCB Rotation Student (2013) Graduate Student with Prof. Minkui Luo Molecular Pharmacology & Chemistry Program Sloan Kettering Institute Tri-Institutional Training Program in Chemical Biology BS, Tsinghua University, 2013 Email [email protected]

An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.

… Friday, April 1, 2011 Summary An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract. An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown that antibiotics

Our study, published recently in the Annals of Oncology, suggests that the greatest determinants of COVID-19 severity were patient features and comorbidities, such as a history of heavy smoking and chronic obstructive pulmonary disease (COPD).

… Thursday, July 16, 2020 COVID-19 was severe in patients with lung cancer, but deaths were mainly related to patient-specific features, not cancer-specific features or treatments, according to our retrospective study of 102 patients with lung cancer and COVID-19 diagnoses at Memorial Sloan Kettering Cancer

… Job Title Research Scholar Degree MD Start Year 2021 Email [email protected]